Considering that risk stratification is essential, the anti-β2GPI/HLA-DR antibody may help suggest arterial thrombosis, even though they coexist with conventional cardiovascular risk factors, and determine the administration of anticoagulants. The gene discussed is APOH; the disease is Arterial thrombosis.